Presentation
Comparison of the Effects of Myristoylated and Transactivating Peptide (TAT) Conjugated Mitochondrial Fission Peptide Inhibitor (P110) in Myocardial Ischemia/Reperfusion (I/R) Injury
Proceedings of the 24th Annual American Peptide Symposium
Document Type
Article
Publication Date
1-1-2015
Disciplines
Citation Information
Israel Benjamin, Jonathan Vu, Christina Lipscombe, Devon Stutzman, et al.. "Comparison of the Effects of Myristoylated and Transactivating Peptide (TAT) Conjugated Mitochondrial Fission Peptide Inhibitor (P110) in Myocardial Ischemia/Reperfusion (I/R) Injury" Proceedings of the 24th Annual American Peptide Symposium (2015) Available at: http://works.bepress.com/qian_chen/44/
This article was published in Proceedings of the 24th American Peptide Symposium .
The published version is available at http://dx.doi.org/10.17952/24APS.2015.143.Copyright © 2015 APS.